Across TCGA pan-cancer cohorts, HSPE1P13 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of HSPE1P13’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where HSPE1P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HSPE1P13 is over-expressed in tumor.

UCEC, STAD, and LIHC are the cancer types where HSPE1P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HSPE1P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+0.450	.030	2	view →
STAD	Male	III,IV	+0.383	.030	1	view →
LIHC	All	II,III,IV	+0.036	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: HSPE1P13 RNA expression & survival · all HSPE1P13 data types